Safety and weight reduction of sibutramine in the treatment of Thai obese and overweight subjects

Trial Profile

Safety and weight reduction of sibutramine in the treatment of Thai obese and overweight subjects

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Mar 2009

At a glance

  • Drugs Sibutramine (Primary)
  • Indications Obesity
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Abbott Laboratories
  • Most Recent Events

    • 14 Jul 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
    • 14 Jul 2008 The actual completion date for this trial is now 1 Jan 2006 as reported by ClinicalTrials.gov
    • 25 Jun 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top